GKIM
ITCI
GW&K Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-141,109
| Closed | -$18.6M | – | 1050 |
|
|
2025
Q1 | $18.6M | Sell |
141,109
-1,246,353
| -90% | -$164M | 0.17% | 207 |
|
|
2024
Q4 | $116M | Sell |
1,387,462
-6,734
| -0.5% | -$562K | 0.99% | 7 |
|
|
2024
Q3 | $102M | Buy |
1,394,196
+218
| +0% | +$16K | 0.87% | 12 |
|
|
2024
Q2 | $95.5M | Sell |
1,393,978
-204,986
| -13% | -$14M | 0.87% | 13 |
|
|
2024
Q1 | $111M | Sell |
1,598,964
-29,280
| -2% | -$2.03M | 0.98% | 9 |
|
|
2023
Q4 | $117M | Sell |
1,628,244
-63,836
| -4% | -$4.57M | 1.09% | 6 |
|
|
2023
Q3 | $88.1M | Sell |
1,692,080
-35,207
| -2% | -$1.83M | 0.89% | 11 |
|
|
2023
Q2 | $109M | Sell |
1,727,287
-25,780
| -1% | -$1.63M | 1.04% | 7 |
|
|
2023
Q1 | $94.9M | Buy |
1,753,067
+302,685
| +21% | +$16.4M | 0.92% | 11 |
|
|
2022
Q4 | $76.8M | Sell |
1,450,382
-15,453
| -1% | -$818K | 0.78% | 19 |
|
|
2022
Q3 | $68.2M | Buy |
1,465,835
+882,242
| +151% | +$41.1M | 0.75% | 23 |
|
|
2022
Q2 | $33.3M | Buy |
583,593
+34,266
| +6% | +$1.96M | 0.36% | 127 |
|
|
2022
Q1 | $33.6M | Buy |
549,327
+176,007
| +47% | +$10.8M | 0.3% | 151 |
|
|
2021
Q4 | $19.5M | Buy |
+373,320
| New | +$19.5M | 0.16% | 197 |
|